Imfinzi significantly improved overall survival and progression-free survival in ADRIATIC Phase III trial
First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial
First and only immunotherapy to demonstrate survival benefit in this setting in a global Phase III trial
Executes the first project for developing and manufacturing a novel anticancer mAb
Hepatitis B infects over 40 million people in India
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
The investment will catalyse various components of the IndiaAI Mission
The Convocation ceremony was organized for students skilled and certified in Ayush
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
Subscribe To Our Newsletter & Stay Updated